Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The effect of vitamin a supplementation on biochemical parameters in multiple sclerosis patients.
Effects of Inhibitors of the Renin-Angiotensin System on the Efficacy of Interferon beta-1b: A post hoc Analysis of the BEYOND Study.
Cutting Edge: Integrin α4 Is Required for Regulatory B Cell Control of Experimental Autoimmune Encephalomyelitis.
Colestipol May Quickly Eliminate Teriflunomide
Volumetric comparisons of supratentorial white matter hyperintensities on FLAIR MRI in patients with migraine and multiple sclerosis.
Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis.
Binding of recombinant T cell receptor ligands (RTL) to antigen presenting cells prevents upregulation of CD11b and inhibits T cell activation and transfer of experimental autoimmune encephalomyelitis.
Immune status following alemtuzumab treatment in human CD52 transgenic mice.
Genmab Announces Ofatumumab Development Plans in RRMS and NMO
Morphological differentiation of oligodendrocytes requires activation of Fyn tyrosine kinase.
[Evaluation and quantification of spasticity: a review of the clinical, biomechanical and neurophysiological methods].
Tecfidera(®): an approach for repurposing.
Glatiramer acetate-induced acute hepatotoxicity in an adolescent with MS.
Treatment of Relapsing-Remitting Multiple Sclerosis After 24 Doses of Natalizumab: Evidence From an Italian Spontaneous, Prospective, and Observational Study (the TY-STOP Study).
Evidence for the efficacy of interferon beta-1b in delaying the onset of clinically definite multiple sclerosis in individuals with clinically isolated syndrome.
High dose cyclophosphamide preferentially targets naïve T (CD45/CD4/RA+) cells in CIDP and MS patients.
Immunomodulatory effects of Vitamin D in multiple sclerosis.
Vitamin D intake and incidence of multiple sclerosis.
Environmental risk factors for multiple sclerosis. Part I: the role of infection.
The role of T cell apoptosis in nervous system autoimmunity.
Treatment of acute transverse myelitis and its early complications.
Population Pharmacokinetics of Daclizumab High-Yield Process in Healthy Volunteers and Subjects with Multiple Sclerosis: Analysis of Phase I-III Clinical Trials.
Immunology 2013
Effect of Rituximab in Patients With Leucine-Rich, Glioma-Inactivated 1 Antibody-Associated Encephalopathy.
A controlled trial of mitoxantrone in multiple sclerosis: serial MRI evaluation at one year.

Pages